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AbstrACt
Objectives The quality and safety of drug therapy in 
primary care are global concerns. The Pharmacist and 
Data- Driven Quality Improvement in Primary Care (P- DQIP) 
intervention aims to improve prescribing safety via an 
informatics tool, which facilitates proactive management 
of drug therapy risks (DTRs) by health- board employed 
pharmacists with established roles in general practices. 
Study objectives were (1) to identify and prioritise factors 
that could influence P- DQIP implementation from the 
perspective of practice pharmacists and (2) to identify 
potentially effective, acceptable and feasible strategies to 
support P- DQIP implementation.
Design Semistructured face- to- face interviews using a 
Theoretical Domains Framework informed topic guide. The 
framework method was used for data analysis. Identified 
implementation factors were prioritised for intervention 
based on research team consensus. Candidate 
intervention functions, behavioural change techniques 
(BCTs) and policies targeting these were identified from 
the behavioural change wheel. The final intervention 
content and modes of delivery were agreed with local 
senior pharmacists.
setting General practices from three Health and Social 
Care Partnerships in National Health Service (NHS) Tayside.
Participants 14 NHS employed practice pharmacists.
results Identified implementation factors were linked 
to thirteen theoretical domains (all except intentions) 
and six (skill, memory/attention/decision making, 
behavioural regulation, reinforcement, environmental 
context/resources, social influences) were prioritised. 
Three intervention functions (training, enablement 
and environmental restructuring) were relevant and 
were served by two policy categories (guidelines, 
communication/marketing) and eight BCTs (instructions 
on how to perform a behaviour, problem solving, action 
planning, prompt/cues, goal setting, self- monitoring, 
feedback and restructuring the social environment). 
Intervention components encompass an informatics tool, 
written educational material, a workshop for pharmacists, 
promotional activities and small financial incentives.
Conclusions This study explored pharmacists’ 
perceptions of implementation factors which could 
influence management of DTRs in general practices to 
inform implementation of P- DQIP, which will initially be 
implemented in one Scottish health board with parallel 
evaluation of effectiveness and implementation.
bACkgrOunD
The quality and safety of medication use 
in primary care is an increasing concern in 
the UK and internationally. Up to 4% of all 
unplanned hospital admissions are caused by 
preventable adverse drug events (ADEs).1–5 
Older people are particularly at risk of 
drug- related harm, because of their often 
increased susceptibility to ADEs and frequent 
use of polypharmacy, increasing the likeli-
hood of drug therapy risks (DTRs) including 
drug–drug and drug–disease interactions.6 7 
strengths and limitations of this study
 ► This qualitative study used a theory- driven and 
structured approach to identify factors that may in-
fluence the sustained implementation of medication 
safety intervention in primary care Pharmacist and 
Data- Driven Quality Improvement in Primary Care 
(P- DQIP).
 ► The design of the P- DQIP intervention combined 
consideration of theoretically underpinned strat-
egies with knowledge of the local implementation 
context.
 ► The applicability of our findings may be limited to 
settings, in which National Health Service employed 
pharmacists have established roles within general 
practices.
 ► The prioritisation of theoretical domains may be bi-
ased by our previous experience of developing suc-
cessful prescribing safety interventions in primary 
care.
 ► Intervention design that combines theory and expe-
rience limits the ability to test their respective con-
tributions in driving behavioural change.
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Figure 1 The behavioural change wheel. Reproduced from Michie and Atkins.19
In parallel to population ageing, the prevalence of poly-
pharmacy and DTRs is rising8 and so are drug- related 
hospital admissions9 as well as outpatient and emergency 
room visits.10
A number of recent UK trials have evaluated interven-
tions, in which electronic medical records (EMRs) were 
used to identify and target patients with DTRs for review. 
The pharmacist- led information technology intervention 
for medication errors (PINCER) employed pharmacists 
for 12 weeks to identify and review patients with high- risk 
prescribing and monitoring from EHRs.11 In contrast, 
the data- driven quality improvement in primary care 
(DQIP) intervention12 was general practitioner (GP)- led 
and provided education and a small financial incentive to 
promote the use of an informatics tool, which identifies 
and facilitates review of patients with DTRs. Both trials 
demonstrated significant reductions in targeted DTRs. 
However, the impact of the PINCER intervention waned 
after withdrawal of pharmacist support, while reduc-
tions in targeted DTRs were sustained in the year after 
the DQIP intervention ceased (because it led to reduced 
initiation of high- risk prescribing by GPs).11 12 Addition-
ally, the DQIP trial provided some evidence of reduced 
hospital admissions linked to targeted DTRs.12
In spite of these encouraging findings, both DQIP and 
PINCER were limited by their relatively narrow scope 
(small number of targeted DTRs). Addressing the needs 
of older people on multiple drugs requires a much 
broader scope to encompass a range of indicators. For 
example, the Scottish government polypharmacy working 
group has developed 69 indicators to identify older 
people with DTRs linked to 18 ADEs (eg, falls and frac-
tures, bleeding, hypoglycaemia) from EMRs.13 Inevitably, 
a broader scope will lead to identifying more patients 
needing review, which has resource implications.14 In 
response to the GP workforce crisis, all four UK countries 
are currently investing in new posts for pharmacists to 
work alongside general practice teams, with National 
Health Service (NHS) England investing £130 million for 
2000 additional practice pharmacists.15–18
P- DQIP aims to implement and evaluate a DTR manage-
ment intervention that is pharmacist and data driven 
and deliverable, scalable and sustainable in the UK’s 
NHS. Given prior evidence of effectiveness, we plan to 
include in the intervention core elements from PINCER11 
(pharmacist- driven approach) and DQIP12 (informatics 
tool to identify and review patients with DTRs). P- DQIP 
will target a broader range of DTRs relevant to older 
people, and rather than employing new pharmacists (as 
in PINCER), NHS- employed pharmacists already affili-
ated with general practices will work as part of practice 
teams in order to facilitate sustained impact.
The aim of this study was to systematically develop a 
theoretically informed strategy to support implementa-
tion of pharmacist (P- DQIP) in NHS Scotland. To this 
end, it is important to understand factors that may drive 
successful implementation. For the purposes of this 
study, we define implementation factors as characteristics 
of individuals or the environment they work in, which 
may influence the implementation of P- DQIP. The study 
objectives were (1) to identify implementation factors 
from the perspective of practice pharmacists and priori-
tise them for intervention and (2) to identify potentially 
effective, acceptable and feasible strategies to support 
P- DQIP implementation.
MethODs
theoretical framework and study design
The study design draws on guidance on using the 
‘behavioural change wheel (BCW)’19 (figure 1). The 
BCW is based on the capability, opportunity, motivation, 
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Figure 2 Intended drug therapy risk management model 
with behaviours to be targeted by the P- DQIP informatics 
tool. The dotted lines denote potential pathways, that is, 
pharmacists may decide on a DTR management strategy 
with or without prior consultation with patients or other 
clinicians. DTR, drug therapy risk; GP, general practitioner; IT, 
information technology; P- DQIP, Pharmacist and Data- driven 
Quality Improvement in Primary Care.
behaviour (COM- B) change model, which identifies six 
broad influences on behaviour (physical and psycholog-
ical capability, social and physical opportunity, reflec-
tive and automatic motivation). The linked Theoretical 
Domains Framework (TDF)20 consists of 14 overarching 
domains providing a more granular analysis of the influ-
ences on behaviour. The BCW and TDF have been exten-
sively used to design interventions targeting healthcare 
professionals’ behaviour.21 22
The intended process by which drug- related harm can 
be prevented in P- DQIP is shown in figure 2. Based on this, 
the behaviour to be targeted by the P- DQIP intervention 
was defined as pharmacists’ management of DTRs identi-
fied by the P- DQIP tool. To achieve this, pharmacists need 
to accomplish the following key tasks: (1) make clinical 
decisions on whether and which medication changes are 
appropriate; (2) collaborate with other clinicians to agree 
and implement a DTR management strategy; (3) embed 
the P- DQIP work into their work routine. Most pharma-
cists would opportunistically conduct clinical medication 
reviews as part of their existing roles. However, proac-
tively identifying patients with DTRs was a new element 
that was expected (as a minimum) to increase the volume 
of pharmacists’ medication reviews and the frequency of 
pharmacist–GP interaction.
To address objective 1, we conducted semistructured 
face- to- face interviews with practice pharmacists using an 
interview topic guide based on the TDF, and then prior-
itised TDF domains for intervention. For objective 2, we 
mapped candidate intervention functions (ie, mecha-
nisms by which an intervention can change behaviour) 
to prioritised TDF domains using the ‘BCW’.19 23 We used 
this mapping to identify suitable intervention functions, 
behavioural change techniques (BCTs) (ie, the smallest 
‘active ingredients’) and policies (ie, avenues through 
which an intervention is delivered)23–25 via consensus 
discussion within the research team. We agreed the final 
intervention content and delivery formats with local 
stakeholders (one senior practice pharmacists from each 
of three locality teams).
subjects and setting
NHS Tayside has a total of 64 general practices serving 
a population of 425 000 residents with a median list size 
of 6415 (range 1796–13 044) patients across all prac-
tices. General practices are organised geographically 
into three Health and Social Care Partnerships (HSCPs) 
and 12 ‘clusters’, each cluster comprising between two 
and eight practices, who meet regularly to discuss quality 
improvement work. Each practice has at least one prac-
tice pharmacist representative, normally working in 
more than one practice. Their roles in these practices 
vary, but usually include cost- saving work (eg, switching 
patients to less expensive but therapeutically equivalent 
medicines) as well as undertaking complex clinical medi-
cation review. We purposively sampled NHS employed 
practice pharmacists aiming to include pharmacists from 
each of the three HSCP (reflecting pharmacy manage-
ment structure) and with a range of working experience 
as practice pharmacists (which we anticipated to influ-
ence perceptions of implementation barriers). The NHS 
Tayside health board approached a total of 18 practice 
pharmacists on our behalf by email (including partici-
pant information sheet) asking them to get in touch with 
the research team if they were interested in participating. 
Of the pharmacists approached, eight worked in HSCP 1, 
five in HSCP2 and five in HSCP 3. Twelve had more than 
5 years working experience (reflecting larger numbers of 
pharmacists working in HSCP 1 and a disbalance towards 
more experienced practice pharmacists in NHS Tayside 
at the time of the study).
Data collection
The interview topic guide (see online supplementary 
additional file 1) was drafted using the 14 domains of the 
TDF,20 piloted with three practice pharmacists and opti-
mised iteratively to address all TDF domains and to mini-
mise multiple questions yielding similar answers. The two 
interviewers also exchanged experiences after each inter-
view, and iteratively amended the topic guide as required.
Semistructured interviews were conducted by two post-
doctoral research fellows (one male (JT), one female 
(MT)) with backgrounds in health psychology and 
previous experience in conducting semistructured inter-
views. The interviews were conducted between December 
2016 and March 2017 and took place in the pharmacists’ 
place of work. The researchers had no prior relationships 
with any of the participants. The interviewers started the 
interview by providing background on the aims of P- DQIP 
and prespecified components (including paper mock- ups 
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of the core functionalities of the P- DQIP informatics tool, 
namely case finding of patients with high- risk prescribing 
and review facilitation). Participants’ perceptions of 
P- DQIP implementation factors were subsequently 
explored using the topic guide where it was tweaked iter-
atively as needed after each interview (depending on the 
exchange of experiences between the researchers). Inter-
views were audio recorded and transcribed verbatim by 
a professional transcription service. The researchers also 
cross- checked a subsample of four transcripts alongside 
their audio recordings to ensure accuracy of transcribing. 
All audio recordings were stored securely in accordance 
with institutional policies.
Data analysis
Data analysis was conducted by the core research team 
(JT, MT and TD) using NVivo V.11 (for initial identifi-
cation of relevant quotes) and MS Excel (for coding of 
quotes identified as relevant).
Identifying implementation factors (objective 1)
Following a familiarisation process, data analysis was 
conducted in four steps.
The first step applied the framework method21 using 
a deductive approach to code identified implementation 
factors in relation to COM- B and TDF coding. A coding 
guideline (see online supplementary additional file 2) 
was iteratively developed and applied by two coders (JT 
and MT). All quotes were then coded by both researchers 
using this guideline, with disagreements resolved by 
consensus discussion.
The second step inductively developed a coding frame 
to identify specific beliefs among quotes coded to each 
TDF domain in step one. The coding frame was subse-
quently applied independently by two researchers (TD 
and JT), and disagreements were resolved by discussion.
The third step used consensus discussion to iden-
tify ‘expected barriers’ to P- DQIP implementation. An 
expected barrier was defined as a hindrance to P- DQIP 
implementation, which the interviewed pharmacist 
described as likely to occur in his or her own practice 
(rather than merely describing it as a relevant factor).
The final step explored links between theoretical 
domains.
Prioritisation of implementation factors and mapping of 
intervention components (objective 2)
In order to prioritise theoretical domains to be targeted 
by P- DQIP, we considered (as a crude guide) for each 
P- DQIP implementation factor within each theoretical 
domain: (1) how often it was coded; (2) how many partic-
ipants it was coded for; (3) how often it was identified 
as an ‘expected barrier’ and (4) how feasible it was to 
address it as part of the P- DQIP intervention.
The prioritised theoretical domains were mapped onto 
components of the BCW.20 Apart from being potentially 
effective, prospective intervention components needed 
to be acceptable and feasible in the existing NHS context, 
which meant they had to be (1) deliverable by existing 
NHS staff with minimal training; (2) deliverable with 
minimal disruption to primary care clinicians’ routine 
work and (3) involve minimal cost to the NHS. These 
criteria guided a stepwise review of potential intervention 
components by the core research team (JT, MT and TD), 
in which we first identified suitable intervention functions 
among those mapped to each TDF domain in Michie et 
al’s mapping matrix.23 We then used the matrices linking 
intervention functions to policy categories24 and interven-
tion functions to BCTs.25 Through consensus discussion, 
which involved practitioners with substantial experience 
in the health service, ideas on how to address identified 
barriers were explored until a consensus was reached 
before potential delivery mechanisms were agreed and 
intervention components drafted. The draft was subse-
quently presented to three HSCP pharmacy leads in a 
face- to- face meeting, where the final intervention compo-
nents and delivery formats were then finalised.
Patient and public involvement
Feedback on the P- DQIP implementation strategy was 
sought from two public self- selected representatives from 
NHS Tayside who had an interest in research on poly-
pharmacy and risky prescribing within primary care. They 
attended research team meetings to advise on the project 
identifying which components would benefit patients the 
most based on their own experiences of polypharmacy.
results
Participants
Fourteen of the 18 pharmacists approached were 
recruited (4 did not reply after two reminders). Partici-
pants worked in practices in HSCP 1 (n=7), HSCP 2 (n=5) 
and HSCP 3 (n=2). Most pharmacists (n=11) had over 5 
years experience as practice pharmacists and most (n=10) 
worked in two or more practices. Two researchers (MT 
and JT) conducted seven face- to- face interviews each and 
interviews lasted from 30 min to 1 hour. Data saturation 
was reached after 12 interviews. The additional interviews 
were conducted before the point of data saturation was 
established.
Identified implementation factors (objective 1)
A total of 211 quotes (ie, pieces of text judged as part of 
the same argument or thought) were identified as rele-
vant to the target behaviour. The quotes represented 13 
of the theoretical domains (all except ‘intentions’, which 
were defined as explicit expressions of commitment or 
lack thereof, which were less likely given that the inter-
vention was hypothetical at the point of interview) and 
encompassed five COM- B constructs (all except ‘physical 
skills’) (see table 1 for sample quotes). In the following, 
we report findings organised by key pharmacist imple-
mentation tasks as outlined above, namely: (1) clinical 
decision making; (2) collaboration with other clinicians 
and (3) embedding the P- DQIP work in work routines.
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 lo
t 
of
 p
at
ie
nt
s 
w
ith
 a
 lo
t 
of
 d
iff
er
en
t 
co
nd
iti
on
s 
an
d
 s
om
et
im
es
 t
ha
t 
co
nfi
d
en
ce
, i
t 
ju
st
 c
om
es
 w
ith
 e
xp
er
ie
nc
e 
d
oe
sn
’t 
it?
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P
ha
rm
ac
is
t 
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)
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)
11
 (3
)
C
O
M
- B
 c
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st
ru
ct
:
7.
‘I 
w
ou
ld
n’
t 
b
e 
co
nfi
d
en
t 
in
 g
oi
ng
 a
nd
 s
to
p
p
in
g 
so
m
e 
of
 t
he
 a
nt
i-
 p
sy
ch
ot
ic
s 
an
d
 s
ch
iz
op
hr
en
ic
 p
at
ie
nt
s 
an
d
 t
hi
ng
s 
lik
e 
th
at
 if
 t
he
y 
w
er
e 
un
d
er
 m
en
ta
l h
ea
lth
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ha
rm
ac
is
t 
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F 
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ot
io
n
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efl
ec
tiv
e 
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ot
iv
at
io
n
 
 
S
p
ec
ifi
c 
b
el
ie
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xi
et
y
 
 
 
 
 
 
8.
‘I 
fe
el
 a
 g
re
at
er
 w
ei
gh
t 
of
 r
es
p
on
si
b
ili
ty
 w
he
n 
I a
m
 a
ct
ua
lly
 p
re
sc
rib
in
g 
fo
r 
so
m
eb
od
y,
 it
 t
ak
es
 m
e 
q
ui
te
 a
 lo
t 
to
 p
ut
 t
he
 p
en
 t
o 
p
ap
er
 
to
 a
ct
ua
lly
 d
o 
th
e 
p
re
sc
rip
tio
n’
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P
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 c
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: p
sy
ch
ol
og
ic
al
 
ca
p
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F 
d
om
ai
n:
 k
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w
le
d
ge
 
 
 
 
S
p
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ifi
c 
b
el
ie
f: 
ta
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 e
nv
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en
t
9.
‘Y
ou
’v
e 
go
t(…
)to
 u
nd
er
st
an
d
 h
ow
 a
 p
ra
ct
ic
e 
w
or
ks
 a
nd
 h
ow
 it
 in
te
ra
ct
s 
w
ith
 o
th
er
 c
ar
e 
en
vi
ro
nm
en
ts
 …
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P
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S
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un
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o
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va
nt
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te
s
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un
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fl
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ti
ng
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te
d
’ 
b
ar
ri
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o
un
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o
f 
p
ar
ti
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p
an
ts
 
w
it
h 
re
le
va
nt
 
q
uo
te
s 
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o
un
t 
re
fl
ec
ti
ng
 
‘e
xp
ec
te
d
’ 
b
ar
ri
er
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TD
F 
d
om
ai
n:
 s
ki
ll
 
 
 
 
S
p
ec
ifi
c 
b
el
ie
f: 
in
te
rp
er
so
na
l
10
.‘Y
ou
'r
e 
go
in
g 
to
 h
av
e 
to
 g
et
 t
o 
kn
ow
 t
he
 p
eo
p
le
 t
ha
t 
yo
u'
re
 w
or
ki
ng
 w
ith
, a
nd
 I 
th
in
k 
fo
r 
th
e 
fir
st
 li
tt
le
 w
hi
le
 y
ou
 m
ig
ht
 s
ay
 r
ig
ht
 I'
ll 
sp
ea
k 
to
 t
he
 G
P
s 
ab
ou
t 
th
e 
ch
an
ge
s 
fir
st
 o
f a
ll,
 ju
st
 t
o 
d
em
on
st
ra
te
 t
ha
t 
yo
u'
re
 c
ap
ab
le
, y
ou
'r
e 
no
t 
go
in
g 
to
 d
o 
so
m
et
hi
ng
 d
an
ge
ro
us
 
an
d
 y
ou
'r
e 
no
t 
go
in
g 
to
 ju
st
 s
p
en
d
 a
ll 
yo
ur
 t
im
e(
…
)te
lli
ng
 t
he
 p
at
ie
nt
s 
th
at
 t
he
 G
P
s 
ar
e 
ru
b
b
is
h…
’ (
P
ha
rm
ac
is
t 
11
)
15
 (0
)
8 
(0
)
C
O
M
-  B
 c
on
st
ru
ct
: r
efl
ec
tiv
e 
m
ot
iv
at
io
n
 
 
 
 
T
D
F 
d
o
m
ai
n:
 b
el
ie
fs
 a
b
o
ut
 c
ap
ab
ili
ti
es
S
p
ec
ifi
c 
b
el
ie
f: 
p
er
so
na
l s
el
f-
 co
nfi
d
en
ce
11
.‘I
'd
 b
e 
q
ui
te
 h
ap
p
y 
to
 s
ay
, y
ea
h,
 I 
w
ou
ld
 le
ad
 o
n 
th
at
 in
 t
he
 p
ra
ct
ic
e;
 I'
d
 q
ui
te
 h
ap
p
ily
 t
ak
e 
th
at
…
 I'
d
 t
ak
e 
it 
to
 t
he
 G
P
s 
an
d
 s
ay
 
rig
ht
, t
hi
s 
is
 w
ha
t 
w
e'
re
 g
oi
ng
 t
o 
d
o’
. (
P
ha
rm
ac
is
t 
11
)
4 
(0
)
4 
(0
)
TD
F 
d
om
ai
n:
 p
ro
fe
ss
io
na
l/s
oc
ia
l r
ol
e 
an
d
 
id
en
tit
y
 
 
 
 
S
p
ec
ifi
c 
b
el
ie
f: 
p
ro
fe
ss
io
na
l b
ou
nd
ar
ie
s
12
.‘I
 w
ill
 m
ak
e 
m
y 
re
co
m
m
en
d
at
io
ns
, t
he
y’
ll 
b
e 
d
is
cu
ss
ed
 r
ou
nd
 t
he
 t
ab
le
 b
y 
va
rio
us
 p
ro
fe
ss
io
na
ls
 a
nd
 t
he
n 
th
er
e’
ll 
b
e 
a 
d
ec
is
io
n 
m
ad
e 
as
 t
o 
w
he
th
er
 t
he
y’
re
 a
p
p
ro
p
ria
te
 a
ct
io
ns
 o
r 
no
t 
an
d
 h
ow
 t
he
y’
re
 g
oi
ng
 t
o 
b
e 
im
p
le
m
en
te
d
’. 
(P
ha
rm
ac
is
t 
09
)
7 
(0
)
4 
(0
)
C
O
M
- B
 c
on
st
ru
ct
: s
oc
ia
l o
p
p
or
tu
ni
ty
 
 
 
 
TD
F 
d
om
ai
n:
 s
oc
ia
l i
nfl
ue
nc
es
 
 
 
 
S
p
ec
ifi
c 
b
el
ie
f: 
in
te
rp
er
so
na
l t
ru
st
13
.‘M
y 
G
P
s 
ar
e 
lik
e 
th
at
 w
ith
 m
e 
b
ec
au
se
 I’
ve
 b
ee
n 
w
ith
 t
he
m
 fo
r 
a 
lo
ng
 t
im
e 
an
d
 t
he
y 
kn
ow
 w
ha
t 
I c
an
 d
o 
an
d
 w
ha
t 
I d
on
’t.
 T
he
y 
kn
ow
 t
ha
t 
if 
I’m
 in
 d
ou
b
t 
ab
ou
t 
an
yt
hi
ng
 I 
w
ou
ld
 g
o 
an
d
 a
sk
 t
he
m
. I
f y
ou
 s
ee
 w
ha
t 
I m
ea
n?
 T
he
y’
d
 b
e 
su
p
p
or
tiv
e 
of
 m
e,
 w
he
re
as
 I’
m
 
no
t 
so
 s
ur
e 
if 
I w
en
t 
so
m
ep
la
ce
 e
ls
e 
ho
w
 t
ha
t 
w
ou
ld
 b
e 
w
ith
ou
t 
th
os
e 
G
P
s 
kn
ow
in
g 
th
at
 P
ha
rm
ac
is
t 
th
er
e’
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P
ha
rm
ac
is
t 
08
)
21
 (2
)
13
 (1
)
S
p
ec
ifi
c 
b
el
ie
f: 
p
ra
ct
ic
es
’ s
ta
ff 
in
te
re
st
 in
 
co
lla
b
or
at
io
n
14
.‘W
e 
ha
ve
 w
ee
kl
y 
m
ee
tin
gs
, m
ul
tid
is
ci
p
lin
ar
y 
m
ee
tin
gs
 a
nd
 w
e 
d
is
cu
ss
 v
ul
ne
ra
b
le
 p
at
ie
nt
s 
w
ho
 a
re
 m
ay
b
e 
tin
ke
rin
g 
on
 t
he
 e
d
ge
 o
f 
ne
ed
in
g 
ad
m
is
si
on
 t
o 
ho
sp
ita
l a
nd
 m
ay
b
e 
ju
st
 n
ee
d
 a
 li
tt
le
 b
it 
m
or
e 
su
p
p
or
t 
at
 h
om
e’
. (
P
ha
rm
ac
is
t 
10
)
27
 (4
)
8 
(3
)
S
p
ec
ifi
c 
b
el
ie
f: 
p
ra
ct
ic
es
’ p
er
ce
p
tio
n 
of
 
p
ha
rm
ac
is
t 
ro
le
15
.‘I
’m
 c
on
ce
rn
ed
 n
ow
 t
ha
t 
th
ey
 lo
ok
 a
t 
m
e 
an
d
 s
ay
, o
h 
sh
e’
s 
ju
st
 h
er
e 
to
, h
el
p
 c
ut
 c
os
ts
, b
ec
au
se
 I 
th
in
k 
th
ey
 c
an
…
 b
ec
au
se
 it
’s
 
su
ch
 a
 b
ig
 t
hi
ng
 a
nd
 I 
d
on
’t 
th
in
k 
it’
s 
m
e 
th
at
’s
 d
oi
ng
 it
 I 
th
in
k 
it’
s 
th
e 
m
an
ag
em
en
t 
th
at
 a
re
 d
oi
ng
 it
 a
nd
 it
’s
 fi
lte
rin
g 
th
ro
ug
h 
to
 t
he
m
 
…
 I 
d
on
’t 
fe
el
 c
om
fo
rt
ab
le
 w
ith
 t
ha
t 
b
ec
au
se
 I 
th
in
k 
w
e’
re
 t
he
re
 a
s 
a 
q
ua
lit
y 
th
in
g.
 O
b
vi
ou
sl
y 
co
st
 d
oe
s 
co
m
e 
in
to
 it
, b
ut
, t
ha
t 
d
oe
s 
co
nc
er
n 
m
e 
to
 a
 c
er
ta
in
 e
xt
en
t’
. (
P
ha
rm
ac
is
t 
02
)
8 
(3
)
5 
(3
)
S
p
ec
ifi
c 
b
el
ie
f: 
p
ra
ct
ic
es
’ p
er
ce
p
tio
n 
of
 
p
ha
rm
ac
is
t 
sk
ill
s
16
.‘I
f e
ve
ry
 d
ec
is
io
n 
th
at
 t
he
y'
re
 m
ak
in
g 
is
 q
ue
st
io
ne
d
 a
nd
 t
he
 p
ha
rm
ac
is
t 
th
en
 fe
el
s 
th
at
 t
he
y'
re
 u
nw
ill
in
g 
to
 m
ak
e 
an
y 
ch
an
ge
s 
b
ec
au
se
 it
's
 ju
st
 g
oi
ng
 t
o 
co
m
e 
b
ac
k 
an
d
 h
it 
th
em
 in
 t
he
 fa
ce
 k
in
d
 o
f t
hi
ng
’. 
(P
ha
rm
ac
is
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 (2
)
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(2
)
TA
S
K
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: fi
tt
in
g
 P
- D
Q
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to
 w
o
rk
 r
o
ut
in
es
C
O
M
- B
 c
on
st
ru
ct
: P
sy
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ol
og
ic
al
 
ca
p
ab
ili
ty
 
 
 
 
TD
F 
d
om
ai
n:
 b
eh
av
io
ur
al
 r
eg
ul
at
io
n
 
 
 
 
S
p
ec
ifi
c 
b
el
ie
f: 
ac
tio
n/
w
or
k 
p
la
nn
in
g
17
.‘f
 w
e 
ge
t 
th
at
 s
or
t 
of
 s
ys
te
m
 s
et
 u
p
, t
ha
t 
w
ou
ld
 b
e 
fin
e,
 y
ou
 k
no
w
, i
t’s
 n
ot
 t
ha
t 
ki
nd
 o
f t
hi
ng
 I’
m
 w
or
rie
d
 a
b
ou
t.
 It
’s
 a
ct
ua
lly
 h
av
in
g 
th
e 
p
ro
te
ct
ed
 t
im
e 
to
 d
o 
it’
. (
P
ha
rm
ac
is
t 
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 (1
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10
 (1
)
C
O
M
- B
 c
on
st
ru
ct
: r
efl
ec
tiv
e 
m
ot
iv
at
io
n
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om
ai
n:
 p
ro
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ia
l r
ol
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an
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id
en
tit
y
 
 
 
 
S
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c 
b
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ie
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p
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fe
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io
na
l i
d
en
tit
y
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.‘T
he
 c
or
e 
of
 o
ur
 jo
b
 is
 p
at
ie
nt
 s
af
et
y 
an
d
 t
he
se
 d
ru
gs
 a
re
 o
b
vi
ou
sl
y 
ve
ry
, v
er
y 
ris
ky
 t
o 
p
at
ie
nt
s,
 s
o 
I t
hi
nk
 t
he
y 
[o
th
er
 p
ha
rm
ac
is
ts
] 
sh
ou
ld
 b
e 
en
ga
ge
d
’. 
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o
S
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o
un
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o
f 
re
le
va
nt
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s
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o
un
t 
re
fl
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ti
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‘e
xp
ec
te
d
’ 
b
ar
ri
er
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C
o
un
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o
f 
p
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p
an
ts
 
w
it
h 
re
le
va
nt
 
q
uo
te
s 
(c
o
un
t 
re
fl
ec
ti
ng
 
‘e
xp
ec
te
d
’ 
b
ar
ri
er
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TD
F 
d
om
ai
n:
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el
ie
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b
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t 
co
ns
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nc
es
 
 
 
 
S
p
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c 
b
el
ie
f: 
re
vi
ew
 p
ro
ce
ss
19
.‘T
he
 p
os
iti
ve
 w
ou
ld
 b
e 
fo
r 
m
e,
 it
 w
ou
ld
 m
ak
e 
p
ol
yp
ha
rm
ac
y 
re
vi
ew
s 
a 
lo
t 
ea
si
er
 a
nd
 g
iv
e 
yo
u 
ar
ea
s 
to
 fo
cu
s 
on
 w
hi
ch
 is
 g
oo
d
’. 
(P
ha
rm
ac
is
t 
12
)
24
 (0
)
12
 (0
)
S
p
ec
ifi
c 
b
el
ie
f: 
p
at
ie
nt
 b
en
efi
t
20
.‘H
el
p
in
g 
to
 r
ed
uc
e 
th
e 
hi
gh
 r
is
k 
p
re
sc
rib
in
g 
b
as
ic
al
ly
 a
nd
 h
el
p
 s
om
e 
of
 t
he
 p
at
ie
nt
s 
ou
t 
th
er
e 
th
at
 s
ho
ul
d
n’
t 
b
e 
on
 d
ru
gs
 t
ha
t 
th
ey
 
ar
e 
cu
rr
en
tly
 o
n 
an
d
 h
ar
m
in
g 
th
em
. W
el
l, 
yo
u’
re
 g
oi
ng
 t
o 
st
op
 t
he
m
 fa
lli
ng
, e
nd
in
g 
up
 in
 h
os
p
ita
l. 
S
om
e 
of
 t
he
 d
re
ad
fu
l s
id
e 
ef
fe
ct
s 
th
at
 s
om
e 
of
 t
he
 d
ru
gs
 h
av
e.
 A
 lo
t 
of
 t
he
m
 d
on
’t 
re
al
is
e 
th
ey
’v
e 
go
t 
a 
d
ry
 m
ou
th
 b
ec
au
se
 o
f t
he
ir 
d
ru
gs
…
’ (
P
ha
rm
ac
is
t 
08
)
6 
(0
)
6 
(0
)
TD
F 
d
om
ai
n:
 o
p
tim
is
m
 
 
 
 
S
p
ec
ifi
c 
b
el
ie
f: 
p
os
iti
ve
 a
tt
itu
d
es
21
.‘Y
es
, i
t 
is
 s
om
et
hi
ng
 e
ls
e 
to
 d
o 
b
ut
, i
f w
e 
d
o 
th
is
 it
 w
ill
 h
op
ef
ul
ly
 h
el
p
 p
re
- e
m
p
t 
p
r o
b
le
m
s 
in
 t
he
 lo
ng
 r
un
’. 
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ha
rm
ac
is
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8 
(0
)
7 
(0
)
TD
F 
d
om
ai
n:
 g
oa
ls
 
 
 
 
S
p
ec
ifi
c 
b
el
ie
f: 
p
ro
fe
ss
io
na
l r
ec
og
ni
tio
n
22
.‘W
he
n 
I d
id
 t
he
 P
ol
yp
ha
rm
ac
y 
p
ilo
t 
I w
as
 w
or
ki
ng
 la
te
 e
ve
ry
 n
ig
ht
 b
ec
au
se
 I 
w
as
 d
oi
ng
 t
hi
s 
re
al
ly
 in
 a
d
d
iti
on
 t
o 
m
y 
ot
he
r 
w
or
k.
…
 I 
w
an
te
d
 it
 t
o 
b
e 
d
on
e 
p
ro
p
er
ly
 s
o 
I i
nv
es
te
d
 a
 lo
t 
of
 m
y 
en
er
gy
 a
nd
 t
im
e 
to
 d
oi
ng
 t
ha
t 
…
 m
ay
b
e 
I w
ou
ld
n’
t 
d
o 
it 
in
 s
o 
m
uc
h 
d
ep
th
 n
ow
 
b
ut
, a
t 
th
at
 p
oi
nt
, I
 d
id
 w
an
t 
to
 k
no
w
…
 b
ec
au
se
 w
e 
w
er
e 
at
 t
he
 b
eg
in
ni
ng
. T
he
 fi
rs
t 
tim
e 
I’d
 w
or
k 
w
ith
 t
he
 C
on
su
lta
nt
 a
nd
 t
he
 G
P
 
to
ge
th
er
 s
o 
I w
an
te
d
 t
o 
p
re
- e
m
p
t 
an
y 
q
ue
st
io
ns
 I 
w
ou
ld
 b
e 
as
ke
d
’. 
(P
ha
rm
ac
is
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 (0
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(0
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S
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ifi
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23
.[i
n 
a 
p
re
vi
ou
s 
m
ul
tid
is
ci
p
lin
ar
y 
p
ro
je
ct
 o
n 
p
ol
yp
ha
rm
ac
y]
 t
he
 c
on
su
lta
nt
 fr
om
 M
ed
ic
in
e 
fo
r 
th
e 
E
ld
er
ly
 w
as
, v
er
y 
m
uc
h 
ta
ki
ng
 t
he
 
le
ad
,…
 s
o 
th
er
e 
w
as
 a
 c
er
ta
in
 a
m
ou
nt
 o
f p
ro
fe
ss
io
na
l s
at
is
fa
ct
io
n 
b
ut
 n
ot
, n
ot
 t
he
 s
am
e 
as
 y
ou
 w
ou
ld
, i
f y
ou
 w
er
e 
ac
tu
al
ly
 d
oi
ng
 t
he
 
re
vi
ew
 o
n 
yo
ur
 o
w
n’
. (
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S
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ie
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p
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ue
s
24
.‘A
s 
yo
u'
re
 d
oi
ng
 it
 t
ha
t 
w
ou
ld
 b
e 
a 
w
ay
 t
o 
p
ro
m
p
t 
yo
u,
 a
nd
 a
s 
I s
ai
d
 if
 y
ou
 s
ee
 o
ne
 y
ou
 m
ig
ht
 g
o 
an
d
 s
ea
rc
h 
fo
r 
p
at
ie
nt
s 
on
 s
ay
, I
 
m
ea
n…
 t
he
re
's
 s
om
e 
co
m
p
ut
er
 s
ys
te
m
s 
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Task 1: clinical decision making
Most pharmacists identified up- to- date pharmacothera-
peutic knowledge (knowledge; quote 1) as being essential 
to managing DTRs appropriately. Although participants 
generally felt their undergraduate education equipped 
them with the necessary knowledge and skills, some high-
lighted the need for selective ‘upskilling’ to manage infre-
quent/unfamiliar DTRs (skills; quote 3). Having been 
shown the functionalities of the informatics tool, pharma-
cists expressed that it could help direct attention to DTRs, 
which may otherwise be overlooked (memory, attention 
and decision making; quote 5). Pharmacists’ confidence 
in clinically managing DTRs appeared strongly associated 
with relevant experience of working as a practice pharma-
cist (beliefs about capabilities, quote 6). However, several 
pharmacists identified complex therapeutic scenarios 
that required discussion by the wider multidisciplinary 
team irrespective of experience and skill (beliefs about 
capabilities; quote 7). Some pharmacists felt their limited 
knowledge of patients’ personal circumstances prevented 
them from making decisions on DTRs independently 
(knowledge, quote 2). Several pharmacists highlighted 
their role was to advise or recommend a course of action 
to manage DTRs, but that the ultimate decision lay with 
other professionals (professional/social role and iden-
tity; quote 12). A few pharmacists expressed anxiety 
about making certain clinical decisions independently 
(emotion; quote 8), while others highlighted that such 
independence could lead to a higher level of professional 
satisfaction (goals; quote 23).
Task 2: collaboration with other clinicians
Most felt that for pharmacists to lead on DTR manage-
ment in a particular practice, familiarity with practice 
processes and systems (knowledge, quote 9) was essential. 
Interpersonal skills (skills, quote 10) and actual expe-
rience of working with other clinicians in the practice 
(social influences, quote 13) was seen as crucial to win or 
maintain their trust. Personal self- confidence (as a char-
acter trait) was deemed important when engaging with 
other clinicians in managing DTRs (beliefs about capa-
bilities, quote 11). Some pharmacists reported to have 
accomplished a good working relationship with other 
clinicians in the practice (social influences; quotes 13, 
14). However, despite efforts to integrate with practice 
teams, others felt that GPs perceived their primary role 
as a resource for cost- cutting (social influences; quote 15) 
and that GPs scepticism about their clinical skills (social 
influences, quote 16) were barriers to pharmacist–GP 
collaboration in DTR management. Feelings of frustra-
tion on misconceptions of the pharmacists’ role (social 
influences, quote 15) and lack of trust in their capabili-
ties by practice staff were evident (social influences, quote 
16). Some believed that GP staff shortages limited oppor-
tunities to discuss and agree on strategies on how best 
to manage DTRs (environmental context and resources; 
quote 31).
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Task 3: embedding the P-DQIP work into work routines
Most pharmacists appeared motivated to implement the 
P- DQIP work. Several pharmacists expressed that medi-
cation reviews and patient safety were strongly aligned 
with their professional identity (professional/Social Role 
and Identity; quote 18), and valued the P- DQIP work as 
a potential means to achieve further recognition as clini-
cians by the wider primary care team (goals; quote 22). 
Half also expected tangible clinical benefits for patients 
(beliefs about consequences; quote 20). Most pharma-
cists were positive that using the P- DQIP informatics tool 
would support them in managing DTRs, despite expec-
tations of increased workload (Optimism; quote 21). 
Although the majority of pharmacists thought that the 
informatics tool would make the review process more 
efficient and structured (quote 19), most expected diffi-
culties in fitting review of patients proactively identified 
by the P- DQIP informatics tool into their work routines. 
A prominent theme was the perceived high workload 
of routine tasks (environmental context and resources; 
quotes 27–29), including cost- saving projects and medi-
cines reconciliation after hospital discharge, which could 
at least partly be delegated to pharmacy technicians (envi-
ronmental context and resources; quote 30).
As strategies to engage pharmacists in the P- DQIP work, 
some mentioned there was a need for protected time 
(quote 17). Several pharmacists expected that prompts 
to specific DTRs delivered by the P- DQIP tool during 
reviews could encourage them to address such DTRs 
systematically at practice level (reinforcement; quote 24). 
Feedback and peer comparison (eg, on reductions in 
targeted prescribing) were viewed favourably as strategies 
to encourage and maintain pharmacists’ engagement 
(quote 26). In contrast, purely quantitative targets set by 
line managers (eg, a minimum number of reviews per 
week) were viewed as a disincentive to address DTRs that 
are more complex or time consuming to manage (quote 
25).
Interactions between TDF domains
While participants generally believed pharmacists’ profes-
sional skills (knowledge and skills, professional role and 
identity) enabled them to undertake the P- DQIP work, 
self- perceived levels of capability (beliefs about capabili-
ties) varied depending on experience. Although pharma-
cists expressed a personal and/or professional desire to 
engage in the P- DQIP work (beliefs about consequences), 
fitting the work into their routines (behaviour regulation), 
was limited by competing demands on pharmacists’ time 
imposed by NHS line managers and practices (environ-
mental context and resources). Nevertheless, pharmacists 
believed that the informatics tool could make the process 
of identifying and reviewing DTRs more efficient (beliefs 
about consequences) and effective (memory, attention 
and decision making). In terms of social influences, prac-
tices’ expectations of the pharmacists’ role (clinical vs 
cost cutting work), their skills, and the level of trust in 
their profession and as individuals were all reported to 
influence beliefs about capabilities. These could also be 
limited by a lack GP availability to agree on medication 
changes (environmental context and resources), which 
in turn may be driven by GPs’ competing demands and/
or a lack of interest in DTR management and/or collabo-
ration with pharmacists (social influences).
Prioritisation of theoretical domains and mapping of 
intervention components (objective 2)
Table 2 shows theoretical domains prioritised and not 
prioritised for intervention for each of the three key 
pharmacist tasks as above. In the following, we outline the 
rationale for prioritisation and the selection of interven-
tion functions, BCTs and policies for prioritised theoret-
ical domains for each task.
Task 1: clinical decision making
In order to support pharmacists’ capability to make 
appropriate clinical decisions, we prioritised the TDF 
domains skill, memory/attention/decision making and 
reinforcement. The prespecified functionalities of the 
P- DQIP informatics tool included case- finding patients 
with DTRs (BCT: prompts/cues targeting memory/
attention/decision making) as well as prompts to 
specific DTRs in individual patients (BCT: prompts/cues 
targeting reinforcement). In order to address varying 
clinical skills by pharmacist and by DTR, it was decided 
that we would supplement DTR prompts by brief guid-
ance on the management of each DTR within the P- DQIP 
informatics tool and provide more detailed evidence 
and guidance around targeted DTRs in an accompa-
nying manual (BCTs: instructions on how to perform a 
behaviour targeting skill). Although potentially more 
effective, we considered it unfeasible to provide (and for 
pharmacists to attend) comprehensive face- to- face educa-
tion and training for the broad range of targeted DTRs 
within currently available resources.
Task 2: collaboration with other clinicians
A key rationale for designing a pharmacist- driven inter-
vention was to enhance the capacity of primary care 
teams to systematically manage DTRs. A prerequisite to 
realising such benefits is that GPs are willing to dele-
gate DTR management tasks to pharmacists, which 
depends on trust. On the other hand, some involve-
ment of GPs in DTR management continues to be 
required, not least because of legal constraints (not all 
pharmacists are licensed prescribers). The discrepan-
cies between their own and GPs’ perceptions of their 
professional role reported by some pharmacists and 
a lack of trust in their clinical skills and capability are 
potential barriers to P- DQIP implementation, and so 
is a lack of engagement of GPs in DTR management 
and interest in collaboration with pharmacists. While 
P- DQIP could increase opportunities to develop trust, it 
is highly unlikely that a single intervention will change 
such perceptions much. To begin to promote collabo-
rative working between GPs and practice pharmacists 
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in general practices, we considered formal interpro-
fessional education and action planning exercises. 
However, additional costs (GP locum fees), and poor 
attendance because of current GP staff shortages may 
prevent them from successful implementation. We have, 
therefore, decided to target pharmacists and GPs sepa-
rately. We plan to support pharmacists by providing a 
platform for more experienced pharmacists to provide 
support to their peers. Pharmacists affiliated with prac-
tices in the same cluster will therefore participate in a 
moderated workshop to reflect on potential implemen-
tation barriers in their own settings and jointly develop 
strategies to overcome them, including an analysis of 
interprofessional or interpersonal barriers and strate-
gies to engage GP’s and win their trust (BCT: problem 
solving targeting skill). Additionally, we plan to engage 
GPs via strategies that have been successfully applied 
in the GP- led DQIP intervention,26 27 namely encour-
aging practices to use the P- DQIP tool for systematic 
DTR management (policy: communication/marketing 
targeting social influences), provision of a web- based 
tool to enable practices to monitor trends in patients 
with targeted DTRs over time (BCT: self- monitoring 
targeting social influences) as well as small financial 
incentives (BCT: restructuring the social environment 
targeting social influences). Rather than an uncondi-
tional participation fee (as in DQIP), payment (GBP 
450) in P- DQIP will be conditional on practices (1) 
nominating a lead GP for P- DQIP, (2) providing 
evidence of a meeting between the lead GP and prac-
tice pharmacist, in which a strategy for initiating and 
maintaining the practice’s engagement in the P- DQIP 
work is agreed and (3) providing evidence of using the 
P- DQIP tool to monitor their progress in reviewing and 
reducing targeted prescribing.
Task 3: embedding the P-DQIP work into pharmacists’ work 
routines
The competing demands on pharmacist time inflicted 
on pharmacists by their health board employers as well 
as practices were a prominent theme in pharmacist 
interviews. A health board policy protecting pharmacist 
time for the P- DQIP work (as requested by one phar-
macist) proved unfeasible. As an alternative, we aim to 
support pharmacists through training in time manage-
ment (BCT: action- planning targeting skill) and goal 
setting (BCT: goal setting targeting behavioural regu-
lation) as part of a moderated workshop (please see 
'Task 2: collaboration with other clinicians' for further 
details). Since we expect the number of patients with 
DTRs identified by the informatics tool to exceed those 
manageable in a single effort, a stepwise approach 
to implementation will be adopted, where a smaller 
number of DTRs will be targeted initially in order to 
support pharmacists in planning and structuring the 
workload over time (policy: guideline targeting envi-
ronmental context and resources). In order to maintain 
pharmacists’ engagement over time, we will additionally 
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Figure 3 Final components of the P- DQIP intervention. Components are colour coded in terms of which COM- B category they 
primarily target (red: psychological capability; yellow: automatic motivation; amber: reflective motivation; light green: physical 
opportunity; dark green: social opportunity). Delivery mechanisms and content are numbered and specified in text below. (1) 
P- DQIP informatics tool integrated into existing Medicines management software (Scottish Therapeutics Utility): (1a) Search 
engine to identify patients triggering 18 composite and 69 individual indicators of drug therapy risks; (1b) Structured summaries 
of a patient’s ongoing medical problems, investigations and current medications; (1c) Highlighting of a patient’s identified 
drug therapy risks and brief management instructions; (1b) Facility to run weekly reports on the number of medication reviews 
submitted via the P- DQIP tool, with further details on medication changes, follow- up actions and time taken; (1e) Web- based 
application allowing practices to compare levels and trends of targeted prescribing to practices in their ‘cluster’, their HSCP 
and the health board. (2) Written educational material providing referenced evidence and guidance around targeted prescribing. 
(3) Half- day workshop with pharmacists affiliated with practices in the same ‘cluster’, moderated by P- DQIP lead pharmacists. 
Introduction of action planning instruments, goal setting and opportunity for pharmacists to discuss anticipated implementation 
problems and solutions. (4) Phased implementation of the review work with initial focus on patients at increased risk of a small 
number of specific adverse drug events. (5) Request to attend routine meetings of GP clusters by P- DQIP lead pharmacists 
to promote the use of the P- DQIP informatics tool to identify and facilitate the review of patients with DTRs and to monitor 
progress towards reducing targeted prescribing at practice and cluster levels. (6) Offer of payment of £450 per practice, which 
is conditional on providing evidence of conducting the following tasks: (1) Nominate a GP- lead for P- DQIP; (2) GP- pharmacist 
meeting to assign roles and responsibilities in P- DQIP work; (3) ongoing support for pharmacists in managing DTRs identified 
by the P- DQIP tool; (4) number of patients with DTRs reviewed by the practice over the P- DQIP intervention period. COM- B, 
Capability- Opportunity- Motivation- Behaviour; DTR, drug therapy risk; GP, general practitioner; HSCP, Health and Social Care 
Partnership; P- DQIP, pharmacist and data driven quality improvement in primary care.
provide information technology (IT) functionality to 
facilitate self- monitoring of review activity and trends in 
the numbers of patients with targeted DTRs (BCT: self- 
monitoring of behaviour targeting behavioural regula-
tion). In order to emphasise the importance that health 
boards assign to DTR management, line managers will 
request that pharmacists report on their DTR manage-
ment activity on a monthly basis as they are currently 
doing for other routine tasks (BCT: monitoring of 
behaviour by others targeting reinforcement).
Figure 3 shows a diagram depicting the design of 
the P- DQIP intervention, which in the broadest terms 
comprises two elements aiming to (1) facilitate the 
identification and review of patients with DTRs and (2) 
maintain professional engagement and collaboration in 
this process.
DIsCussIOn
summary of findings
We systematically explored key implementation of a 
data and pharmacist- driven DTR management system 
(P- DQIP) from the perspective of NHS employed phar-
macists (who will implement the intervention). Despite 
drawing on previously tested intervention components 
(an informatics tool with core functionalities (DQIP 
trial), and a pharmacist- led review model (PINCER trial)), 
we anticipated likely implementation and adoption 
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challenges arising from the broadened scope and number 
of targeted patients, and from altering and/or adding to 
the work of NHS employed pharmacists with established 
roles in general practices. Consistent with the Medical 
Research Council complex interventions framework,28 
we, therefore, considered it essential to better under-
stand such challenges and identify potential strategies to 
address them before embarking on a wider implementa-
tion and evaluation of effectiveness. We used the TDF to 
comprehensively examine factors that could mediate (ie, 
support or hinder) P- DQIP implementation.20 Pharma-
cists felt that the core functionalities of the P- DQIP IT 
tool could address barriers relating to memory/atten-
tion and decision making (via prompts/cues). However, 
additional BCTs and/or policies were judged necessary 
to overcome barriers relating to five other TDF domains 
(skills, behavioural regulation, reinforcement, environ-
mental context and resources, and social influences). 
Based on the interview data, these intervention compo-
nents had the potential to positively influence pharma-
cists’ beliefs in their capabilities, which were found to be 
key to the implementation of a DTR management system 
that is pharmacist driven.
Comparison to previous research
The notion that pharmacists are an underused clin-
ical resource has stimulated a considerable amount of 
research on pharmacist- led interventions in primary 
care. Most previous evaluations, however, focus on ‘non- 
dispensing’ or ‘cognitive’ services delivered by commu-
nity pharmacists (as opposed to practice pharmacists 
employed by a healthcare funder, such as the NHS) and 
the design of interventions found in such evaluations are 
rarely explicitly theory based.29 An exception is a qualita-
tive study by Cadogan et al,22 in which the authors used 
the TDF—similar to this study—to guide selection of 
intervention components targeting prescribing (by GPs) 
and dispensing (by community pharmacists) for older 
people with polypharmacy in primary care. The theoret-
ical domains prioritised for intervention by Cadogan et al 
broadly match the ones selected in this study, and all but 
one BCT (‘social processes of encouragement/support’) 
selected by Cadogan et al were also selected by us. Never-
theless, a noteworthy difference is our prioritisation of 
reinforcement, which reflects our intention to facilitate 
the sustained implementation of the P- DQIP intervention 
in NHS Scotland, rather than designing an intervention 
for evaluation in a randomised controlled trial. For the 
same reason, we additionally include a number of BCTs 
and locally agreed policies to encourage and maintain 
pharmacist- driven DTR management (goal setting, self- 
monitoring of behaviour, monitoring of behaviour by 
others, promotion/marketing, guidelines). A further 
difference is our focus on informatics tools as a delivery 
mechanism for BCTs (cues/prompts, education, feed-
back), which was enabled by our opportunity to build on 
medicines management software which is available in all 
Scottish GP practices, and which can interrogate prac-
tices’ EMRs and generate reports.
strengths and limitations
This study uses a theory- based systematic approach to 
design a strategy to support the implementation of a 
pharmacist- driven DTR management process in UK 
general practice. By describing our stepwise approach, 
starting with the specification of the target behaviours, 
identification and prioritisation of implementation 
factors, and finally, the selection of BCTs and policies, 
we provide complete transparency in our choice of inter-
vention components optimising them for effective imple-
mentation. We used the framework method applying the 
widely used COM- B and TDF in conjunction with a system-
atic coding process, which was produced from a subset of 
the interviews. Further, we collaborated closely with local 
stakeholders to ensure that intervention components 
were feasible, acceptable and deliverable by existing NHS 
staff.
The main limitation of the study is that our findings 
may only apply to the context in which it was conducted, 
and therefore, may not represent the perspectives of 
practice pharmacists in general. Specifically, all inter-
viewed pharmacists had established roles within their 
affiliated practice(s) and most had more than 5 years of 
experience working as practice pharmacists meaning that 
perspectives could be different in contexts where primary 
care pharmacy is less well established. Nevertheless, the 
proactive identification, review and management of DTRs 
as the target behaviour of the P- DQIP intervention, was 
novel to all participants, and we identified implementa-
tion barriers (eg, practices’ trust in pharmacists’ skills) 
that would be expected to be more prominent among 
pharmacists with less working experience in general or in 
the practices they work in. It is also possible that the prior-
itisation of theoretical domains and selection of interven-
tion strategies was biased by our previous experience of 
developing successful prescribing safety interventions in 
primary care.12 However, by systematically considering 
intervention strategies based on mapping recommenda-
tions, we minimised the risk of omitting relevant theoret-
ically underpinned alternative or additional strategies. 
Furthermore, the theoretical domains prioritised for 
intervention in this study broadly matched those identi-
fied in a similar study targeting community pharmacists,22 
which, taken together, affirms their relevance to current 
policies which aim to extend pharmacists’ clinical roles 
in primary care. Although the intervention design draws 
on an enhanced local infrastructure, implementing the 
IT components of the intervention would be possible 
(in principle) in any healthcare setting, where electronic 
health records are used. The study used experiential 
alongside theoretically underpinned design of interven-
tion strategies. Although a pragmatic approach to inter-
vention development, we acknowledge that it limits the 
ability to examine the respective contributions of theory 
and experience in driving behavioural change.
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COnClusIOns
The findings of this study are of particular relevance 
to the UK context, which has recently seen substantial 
investment in practice pharmacist posts to improve medi-
cines management and reduce GP workload. Our study 
suggests that pharmacists’ belief in their capabilities is a 
key factor influencing their capacity to extend their clin-
ical roles, and this was, in turn, limited by their existing 
skill sets, available resources (including managing time 
in the face of conflicting demands), and underdeveloped 
working relationships with GPs.
The design of the optimised P- DQIP implementation 
strategy demonstrates that providing tools and training 
pharmacists alone is likely to be insufficient to sustain 
pro- active identification and management of patients 
with DTRs by teams of pharmacists and GPs. Aligning 
pharmacists’ roles with the stepwise attainment of measur-
able practice- level performance goals may be one way of 
stimulating and maintaining concerted action by these 
professionals.
More broadly, comparison of the optimised P- DQIP 
intervention to an intervention with similar objectives 
developed by Cadogan et al highlights that intervention 
design choices are influenced by local implementation 
challenges as well as local opportunities to address them. 
While this may compromise the applicability of evaluation 
findings in other healthcare contexts, process evaluations 
can be used to help understand both the relative impor-
tance of intervention components and their interactions 
with local implementation context.
The P- DQIP intervention will be implemented in all 
practices in one NHS Scotland health board and eval-
uated in an interrupted time series study with parallel 
process evaluation to examine its implementation and 
effectiveness.
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